Lantern Pharma (LTRN) Exchange Rate Effect (2022 - 2026)
Lantern Pharma's (LTRN) quarterly Exchange Rate Effect came in at $17585.0 in Q1 2026, up 527.59% YoY from $2802.0 in Q1 2025, and up 494.09% on a QoQ basis from $2960.0 in Q4 2025.
Lantern Pharma (LTRN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 5 years of Exchange Rate Effect data on file, last reported at $17585.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 527.59% year-over-year to $17585.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48209.0 (up 230.59% YoY) and the FY2025 annual result came in at $33426.0, up 167.46% from the prior year.
- Exchange Rate Effect advanced to $17585.0 in Q1 2026, from $2960.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $27925.0 in Q2 2025 to a low of -$67207.0 in Q4 2024.
- A 5-year average of -$2212.1 and a median of $2278.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 1296.36% — and 2026, when it jumped 527.59%.
- Tracing LTRN's Exchange Rate Effect over 5 years: stood at $9901.0 in 2022, then tumbled by 148.61% to -$4813.0 in 2023, then slumped by 1296.36% to -$67207.0 in 2024, then surged by 104.4% to $2960.0 in 2025, then soared by 494.09% to $17585.0 in 2026.
- The last three Exchange Rate Effect figures came in at $17585.0 (Q1 2026), $2960.0 (Q4 2025), and -$261.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Lantern Pharma | 26.33 Mn | 26.33 Mn | - | 17,585.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,585.00 |
| Mar 31, 2026 | 17,585.00 |
| Dec 31, 2025 | 2,960.00 |
| Dec 31, 2025 | 2,960.00 |
| Sep 30, 2025 | -261.00 |
| Sep 30, 2025 | -261.00 |
| Jun 30, 2025 | 27,925.00 |
| Jun 30, 2025 | 27,925.00 |
| Mar 31, 2025 | 2,802.00 |
| Mar 31, 2025 | 2,802.00 |
| Dec 31, 2024 | -67,207.00 |
| Dec 31, 2024 | -67,207.00 |
| Sep 30, 2024 | 16,168.00 |
| Sep 30, 2024 | 16,168.00 |
| Jun 30, 2024 | 11,322.00 |
| Jun 30, 2024 | 11,322.00 |
| Mar 31, 2024 | -9,830.00 |
| Mar 31, 2024 | -9,830.00 |
| Dec 31, 2023 | -4,813.00 |
| Dec 31, 2023 | -4,813.00 |